Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

MicroRNAs as regulators of VEGFA and NFE2L2 in cancer

Full text
Author(s):
Cuzziol, Caroline Izak [1] ; Urbanin Castanhole-Nunes, Marcia Maria [1] ; Pavarino, Erika Cristina [1] ; Goloni-Bertollo, Eny Maria [1]
Total Authors: 4
Affiliation:
[1] Fac Med Sao Jose do Rio Preto FAMERP, Unidade Pesquisa Genet & Biol Mol, Sao Jose Do Rio Preto, SP - Brazil
Total Affiliations: 1
Document type: Review article
Source: Gene; v. 759, OCT 30 2020.
Web of Science Citations: 0
Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that are involved in post-transcriptional regulation of various genes, and their deregulation can lead to tumorigenesis. They may play the role of oncogenes or tumor suppressors by regulating different genes involved in cellular processes. One of the genes regulated by the miRNAs is the vascular endothelial growth factor A (VEGFA), which is responsible for angiogenesis. Angiogenesis is the process of formation of new blood vessels from pre-existing ones. This process plays an important role in tumor development, since it is responsible for the transport of nutrients required for tumor growth. Several studies have shown an increased expression of VEGFA in various cancers. Another gene regulated by miRNAs, the nuclear factor erythroid 2-like-2 (NFE2L2/NRF2), has a cytoprotective function and regulates cellular defense against oxidative stress. The NFE2L2 is the major regulator of cytoprotective agents and their oxidative damage to cells, which is down-regulated by Kelch-like ECH-associated protein 1 (KEAP1) at the post-transcriptional level. Regulation of the VEGFA and NFE2L2 by miRNAs has been observed in hepatocellular carcinoma and breast, lung, esophageal, endometrial, gastric, and ovarian cancer. This review highlights the role of miRNAs in the regulation of VEGFA and NFE2L2 and their relevance as therapeutic targets in various cancers. (AU)

FAPESP's process: 18/26166-6 - Biomarkers and tumor stem cells in the treatment of head and neck cancer
Grantee:Eny Maria Goloni Bertollo
Support Opportunities: Regular Research Grants